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ABSTRACT We report a novel 3-dimensional model
for visualizing tumor cell migration across a nylon
mesh-supported gelatin matrix. To visualize migration
across these model barriers, cell proteolytic activity of
the pericellular matrix was detected using Bodipy-BSA
(fluorescent upon proteolysis) and DQ™ collagen (flu-
orescent upon collagenase activity). For 3-dimensional
image reconstruction, multiple optical images at se-
quential z axis positions were deconvoluted by com-
puter analysis. Specificity was indicated using well-
known inhibitors. Using these fluorescent proteolysis
markers and imaging methods, we have directly dem-
onstrated proteolytic and collagenolytic activity during
tumor cell invasion. Moreover, it is possible to visualize
migratory pathways followed by tumor cells during
matrix invasion. Using cells of differing invasive poten-
tials (uPAR-negative T-47D wild-type and uPAR-positive
T-47D A2–1 cells), we show that the presence of the
T-47D-A2–1 cells facilitates the entry of T-47D wild-type
cells into the matrix. In some cases, wild-type cells
follow T-47D A2–1 cells into the matrix whereas other
T-47D-wild-type cells appear to enter without the direct
intervention of T-47D A2–1 cells. Thus, we have devel-
oped a new 3-dimensional model of tumor cell inva-
sion, demonstrated protein and collagen disruption,
mapped the pathways followed by tumor cells during
migration through an extracellular matrix, and illus-
trated cross-talk among tumor cell populations during
invasion.—Horino, K., Kindezelskii, A. L., Elner, V. M.,
Hughes, B. A., Petty, H. R. Tumor cell invasion of
model 3-dimensional matrices: demonstration of migra-
tory pathways, collagen disruption, and intercellular
cooperation. FASEB J. 15, 932–939 (2001)
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Tumor cell invasiveness is a cardinal feature distin-
guishing malignant from benign disease. Malignant
tumor cells penetrate basement membranes, connec-
tive tissues, and cellular planes (1). Invasiveness re-
quires several distinct cellular functions involved in
tumor cell motility, including adhesion, detachment,
and pericellular proteolysis. Metastatic cells display
increased production of proteolytic enzymes including
lysosomal hydrolyses, collagenases, and plasminogen
activator (2). The expression of certain cell surface
protease receptors is also increased on metastatic cells
(3). Thus, the nature of matrix proteolysis during
tumor cell migration is central to understanding the
invasive cell phenotype (4–8).
A variety of methods have been developed to explore
tumor cell invasiveness (9). In vitro assays of tumor cell
invasiveness include penetration of the urinary bladder
wall (10, 11), human amnion (12, 13), chorioallantoic
membrane (11, 14), blood vessels (11), and lens cap-
sule (15). Reconstituted basement membrane compo-
nents have also been used to assay invasive properties of
tumor cells. Such assays typically involve a layer of
Matrigel atop a porous filter, which is then placed in a
Boyden chamber. The invasive potential of tumor cells
placed in the Boyden chamber can be quantitated by
counting tumor cells across the filter (16). However,
these techniques do not allow for direct optical micros-
copy of a sample nor do they allow for the detection of
biochemical reactions occurring during invasion. We
developed a novel 3-dimensional model based on a
supported gelatin layer that more closely resembles the
physiological environment and permits visualization of




The human fibrosarcoma cell line HT1080 was obtained from
American Type Culture Collection (Bethesda, Md.). HT1080
cells were grown at 37°C in DMEM (Life Technology, Inc.,
Grand Island, N.Y.) supplemented with 10% FBS (Summit
Biotechnology, Fort Collins, Colo.) and 1% PSA (penicillin
G/streptomycin/amphotericin B) (Life Technology). Cells
were grown in sterile flasks and passaged using trypsin-EDTA
(Life Technology), as described previously (17).
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The T-47D and T47 A2–1 cell lines were the generous gifts
of Dr. Robert Todd (Division of Hematology and Oncology,
University of Michigan School of Medicine, Ann Arbor,
Mich.). They were grown at 37°C in RPMI1640 (Life Tech-
nology) supplemented with 10% FBS (Summit), 1% PSA
(Life Technology), and 0.2 IU/ml bovine insulin (Sigma
Chemical Co, St. Louis, Mo.). Cells were passaged as de-
scribed above.
DiI labeling
Labeling tumor cells by DiI (1,19-dioctadecyl-3,3,39,39-tetra-
methylindocarbocyanine; Molecular Probes, Eugene, Oreg.)
was performed according to the method of Kuriyama et al.
(18) with minor modifications. In brief, DiI was prepared as a
2.0 mg/ml solution in DMSO. The DiI solution was routinely
sonicated before application to cells. Cells were detached by
treatment with trypsin-EDTA, suspended with Hank’s bal-
anced salt solution (HBSS) at a concentration of 5 3 105
cells/ml, and stained by incubating with DiI (final concentra-
tion is 20 mg/ml) for 1 h at 37°C with gentle agitation at 15
min intervals. After staining, the cells were washed twice by
centrifugation and seeded onto the surfaces of the gelatin-
nylon mesh.
Nylon membrane preparation
Nylon mesh (125 mm pores, 80% open) cut in 12 mm squares
was rinsed in 75% ethanol for 5 min. A 6% to 10% gelatin
solution was prepared by boiling gelatin in HBSS. To avoid
denaturation of the DQ™ collagen, the solution was allowed
to cool to ;42°C before the addition of this compound. Ten
microliters of cell attachment factor (Cell Systems Corpora-
tion, Kirkland, Wash.) was placed on a coverslip for 15 min at
42°C in an incubator. After drying, a sterile nylon mesh was
placed on the coverslip. Fifty microliters of 6 to 10% gelatin
solution containing 10% fetal bovine serum (FBS) and
Bodipy-BSA (at a final concentration of 1 mg/ml) or DQ™
collagen (at a final concentration of 1 mg/ml) were placed
on the nylon mesh and allowed to harden in a refrigerator at
4°C for 10 min. The gelatin-nylon mesh matrix on the
coverslip was then placed at room temperature.
Transmigration of tumor cells
HT1080 cells were detached from culture flasks by treatment
with trypsin-EDTA. After detachment, the HT1080 cells were
resuspended in culture medium supplemented with 10% FBS
for 10 min at room temperature to inactivate any remaining
trypsin activity. After centrifugation at 1000 rpm for 5 min,
HT1080 cells were seeded onto the surfaces of the gelatin-
nylon mesh matrices in 50 ml of 6% gelatin solution contain-
ing 10% FBS. They were then incubated for 2 to 4 h at 37°C
in a 5% CO2 incubator. The gelatin-nylon mesh matrices and
coverslips were then mounted on glass slides for microscopic
observation.
Inhibition of the collagenase activity
To inhibit metalloproteinase activity, 1,10 phenanthroline
(Eluka Chemical Corp., Ronkonkoma, N.Y.) was used (19).
During preparation of the gel-nylon mesh matrix, 1,10
phenanthroline was incorporated into the matrix at a final
concentration of 10 mM. Control gels contained only etha-
nol, the solvent used for 1,10 phenanthroline. HT1080 cells
were seeded and incubated as described above. After 2 h of
incubation at 37°C, we counted the number of cells with
associated pericellular fluorescence in four high-power mi-
croscopic fields.
Inhibition of urokinase-type plasminogen activator
To inhibit urokinase-type plasminogen activator, PAI-I (plas-
minogen activator inhibitor I; American Diagnostica Corpo-
ration, Joplin, Mo.) was used. During preparation of the
gel-nylon mesh matrix, PAI-I was incorporated into the matrix
at a final concentration of 0.05 mg/ml. Control gels con-
tained only HBSS, the solvent used for PAI-I. HT1080 cells
were seeded and incubated as described above. After 2 h of
incubation at 37°C, we counted the number of cells with
pericellular fluorescence in four high-power microscopic
fields.
Fluorescence Microscopy and Image Reconstruction
To visualize proteolytic activity, Bodipy-BSA (4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a diaza-5-indacene-3-propionic acid-con-
jugated BSA; Molecular Probes) and DQ™ collagen (type IV
from human placenta, fluorescein conjugate; Molecular
Probes cat. no. D-12052) were used. Bodipy-BSA becomes
fluorescent upon exposure to several proteases, especially
urokinase-type plasminogen activator (20). DQ™ collagen
becomes fluorescent upon exposure to collagenase activity.
Bodipy-BSA or DQ™ collagen was incorporated into the
gelatin-nylon mesh matrix layers at a concentration of 1
mg/ml, as described above.
An axiovert inverted fluorescence microscope (IM-135)
with HBO-100 mercury illumination (Carl Zeiss Inc., New
York, N.Y.) interfaced to a Dell 410 workstation (Round Rock,
Tex.) via a Scion SG-7 video card (Vay-Tek, Fairfield, Iowa)
was used. The fluorescence images were collected by an
intensified, cooled charge-coupled device camera (model
XC-77; Hamamatsu Photonics, Bridgewater, N.J.). Images
were processed with ScionImage software and stored as TIFF
files. The fluorescence of Bodipy-BSA and DQ™ collagen
fluorescence was detected using a 485DF22 nm and 530DF30
nm filter combination and a 510 long-pass dichroic mirror
(Omega Optical, Brattleboro, Vt.).
For image reconstruction, images from 50 to 70 optical
sections were taken from a sample. To remove out-of focus
fluorescence, each image was deconvoluted using Mic-
roTome software (Vay-Tek). The 3-dimensional rendering
was performed with VoxBlast software (Vay-Tek). Computa-
tions were performed on a Dell Precision Workstation. Im-
ages were printed using an Epson Stylus-Pro printer.
Imaging spectrophotometry
Fluorescence emission properties of the matrices were stud-
ied using imaging spectrophotometry. Experiments were
performed as described previously (21). Briefly, a Zeiss IM-
135 axiovert microscope was fiber optically coupled to the
input side of an Acton-150 (Acton, Mass.) imaging spectro-
photometer. The exit side was connected to an intensifier,
which was in turn attached to a Peltier-cooled I-MAX-512
camera (Princeton Instruments, Inc., Trenton, N.J.). The
collection of spectra or images was controlled by a high-speed
Princeton ST-133 interface and a Stanford Res. Systems
(Sunnyvale, Calif.) DG-535 delay gate generator. This equip-
ment was interfaced to a Dell 410 workstation running
Winspec/32 version 2.3.2.5 software (Princeton Instruments,
Inc.) to manage image acquisition, quantitate fluorescence
levels, and analyze data. Cells were illuminated using an
optical filter at 485DF22 nm and a 510lp dichroic mirror.
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Statistical analysis
For comparisons, Student’s t tests were performed. Differ-
ences were considered significant at P,0.01 level. Quantita-
tive data are given as the mean 6 sd.
RESULTS
We previously described methodology to detect extra-
cellular proteolysis in gel matrices by using Bodipy-BSA
(20). In the present study, we microscopically examine
the invasiveness of HT1080 cells into 3-dimensional
nylon mesh-supported matrices. To visualize proteoly-
sis, Bodipy-BSA and fluorescein conjugated collagen
(DQ™ collagen; Molecular Probes), which become
highly fluorescent on proteolysis, were used.
We first characterized the fluorescence properties of
nylon mesh-supported matrices containing 1 mg/ml
Bodipy-BSA or DQ™ collagen. Figure 1a shows the
fluorescence emission spectra of Bodipy-BSA-doped
matrices. The dim emission spectrum shows the inher-
ent background fluorescence of the matrix. The com-
panion spectrum of Fig. 1a shows the emission spec-
trum in the presence of an adherent HT1080 cell (15
min at 37°C). Clearly, the total amount of fluorescence
emission is greatly increased in the presence of these
cells. To more specifically image collagenase activity, we
used matrices containing DQ™ collagen in the pres-
ence and absence of adherent tumor cells (Fig. 1b).
Again, there was a substantial increase in fluorescence
intensity, although not as great as that seen for Bodipy-
BSA. In both cases the maximal fluorescence intensity
was observed in the region of 530–550 nm, thus indi-
cating the fluorescein optical filters were appropriate
for imaging.
We next sought to test the ability of certain inhibitors
to effect the generation of pericellular fluorescence on
matrices containing Bodipy-BSA or DQ™ collagen.
Cells were placed on Bodipy-BSA or DQ™ collagen-
doped matrices, then incubated for 2 h at 37°C. The
number of fluorescent sites corresponding to sites of
cell adherence and pericellular proteolysis were then
counted. The number of fluorescent pericellular zones
per high-power microscopic field for the probe-doped
matrices in the presence and absence of protease
inhibitors is shown in Fig. 2. Phenanthioline, a broad-
Figure 1. Fluorescence emission spectra of Bodipy-BSA and
DQ™ collagen in nylon mesh-supported matrices were ob-
tained using imaging spectroscopy. a) The fluorescence emis-
sion spectra of Bodipy-BSA are shown in the presence (solid
line) and absence (dotted line) of attached tumor cells. The
fluorescence emission maximum is 535 nm. b) The fluores-
cence emission spectra of DQ™ collagen are shown in the
presence (solid line) and absence (dotted line) of HT1080
cells. The fluorescence emission maximum is 517 nm. For
both Bodipy-BSA and DQ™ collagen, the emission intensity is
greatly increased in the presence of neighboring cells.
Figure 2. Effect of protease inhibitors on
pericellular fluorescence of Bodipy-BSA (a,
b) and DQ™ collagen (c, d) and in nylon
mesh-supported matrices. Experiments were
conducted in the presence (cross-hatched
bars) and absence (open bars) of 1, 10-
phenanthroline at 10 mM (a, c) and PAI-1
(0.05 mg/ml) (b, d). 1, 10-Phenanthroline, a
metalloproteinase inhibitor, substantially re-
duced the number of fluorescent cells per
high-power microscope field (HPF) in ma-
trices containing DQ™ collagen (c), but had
no effect when tested on Bodipy BSA-con-
taining matrices (a). PAI-1 substantially re-
duced the number of positive cells on both
the Bodipy-BSA (b) and DQ™ collagen (d)
and substrates.
934 Vol. 15 April 2001 HORINO ET AL.The FASEB Journal
spectrum metalloproteinase inhibitor, substantially re-
duced proteolytic disruption of matrices containing
DQ™ collagen, but not those containing Bodipy-BSA
(Fig. 2a, b, respectively). Inasmuch as type IV collagen
is cleaved by metalloproteinases (22), the ability of
phenanthioline to inhibit DQ™ collagen fluorescence
enhancement was expected. Similar experiments were
conducted with the urokinase inhibitor PAI-1 (Fig. 2c,
d). PAI-1 substantially inhibited the proteolysis of
Bodipy-BSA-containing matrices and DQ™ collagen
matrices. The inhibition of Bodipy-BSA cleavage by
PAI-1 was expected based on prior experiments (20).
The inhibitory effect of PAI-1 on collagen disruption
may be partially accounted for by the fact that MMP-2
and MMP-9, which cleave type IV collagen (22), are
activated by urokinase-type plasminogen activator (23).
Another potential contributing factor is the ability of
plasmin to degrade type IV collagen (24). Therefore,
these matrices demonstrate their anticipated functional
sensitivities to proteolytic disruption.
Having established the fluorescence spectroscopic
properties and functional sensitivities of these matrices
to protease inhibitors, we next analyzed proteolytic
detection methods in 3 dimensions using the nylon
mesh-supported matrices. Matrices were prepared us-
ing multiple gel layers supported by a nylon mesh
skeleton, as described above. HT1080 tumor cells were
seeded onto these matrices and incubated for 2 h at
37°C. This incubation time allowed cells to enter and
migrate through this model matrix. We found that the
migratory pathways of the cells in the matrix could be
visualized as a region of proteolytic destruction in the
gel matrices. This simultaneously revealed the migra-
tion pathway in the gel and the nature of proteolytic
action on gel during the tumor cell invasion. Figure 3
shows proteolytic trails in these extracellular gel matri-
ces. Matrices loaded with 1 mg/ml DQ™ collagen or
Bodipy-BSA are shown in Fig. 3a, b, respectively. The
fluorescence emission of hydrolyzed DQ™ collagen or
Bodipy-BSA was photographed at multiple focal planes.
The stacks of multiple images were deconvoluted by
MicroTome software, then reconstructed by VoxBlast
software (see Material and Methods). These images
revealed tracks of proteolytic activity, i.e., tumor cell
migration, through the gel matrices. In general, these
3-dimensional reconstructed images show that the pro-
teolytic signal is most intense near cells and progres-
sively decreases toward the point of cell entry into the
matrix. The reduction in relative signal intensity and
the increase in signal diameter are likely due to the
diffusion of the small, cleaved fluorescent peptides
from the pericellular region. Cell migration during
image acquisition may also cause some blurring of the
image. Figure 3 also shows selected 2-dimensional slices
through the reconstructed image. We observed donut-
shaped regions of fluorescence (Fig. 3b, intermediate
panel on right). Since the cell had already passed this
point and was lower in the matrix, the dark area in the
center likely corresponds to the wound caused in the
matrix by cell migration. Later (further up the migra-
tory trail), the fluorescence became more diffuse. Sim-
ilar properties were noted with matrices containing
DQ™ collagen (Fig. 3a). Thus, protein degradation in
general and collagen disruption in particular are ob-
served during tumor cell invasion of these matrices.
Moreover, this provides a means to visualize the path-
ways followed by cells during invasion.
To illustrate how larger numbers of cells act during
the invasion of these model matrices, experiments were
repeated using different numbers of cells added to the
top of the matrix. Figure 4 shows several independent
repetitions of these experiments. Proteolysis is com-
mon in all transmigration events. The proteolysis of
DQ™ collagen and Bodipy-BSA can both be observed
(Fig. 4a, b, respectively). Most migration pathways were
found to be relatively straight. The lengths of the
proteolytic destruction zones were generally 150 to 200
mm. In 6% gel matrices, the pathways of cell migration
generally were funnel shaped due to diffusion of fluo-
rescent peptide fragments.
Figure 3. 3-dimensional im-




ing DQ™ collagen (a) or
Bodipy-BSA (b). 2-Dimen-
sional cross sections of
these images are shown
along the right hand sides.
The ovals on the 3-dimen-
sional images represent
the areas where slices were
taken as an illustration
of section planes. Scale
bars 5 20 mm.
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To confirm the role of pericellular proteolysis in the
migration of tumor cells across this model matrix, we
determined the fraction of migrated cells in the pres-
ence and absence of protease inhibitors. HT1080 cells
were placed atop a matrix and incubated for 4 h at 37°C
in a humidified incubator. The number of cells reach-
ing the bottom of the matrix was then assessed. The
number of cells reaching the bottom of the matrix
divided by the number of input cells is shown in Fig. 5.
Under the conditions used in these experiments, ap-
proximately one-half of the cells reached the bottom of
the matrix. The fraction of cells reaching the bottom of
the matrix was not significantly affected by the inclu-
sion of 10 mM 1, 10-phenanthroline (Fig. 5b). However,
the fraction of HT1080 cells undergoing transmigra-
tion was dramatically reduced by the inclusion of PAI-1
(Fig. 5a). These differences could not be explained by
changes in cell viability. Cell viability was assessed in the
presence and absence of PAI-1 and 1, 10-phenanthro-
line; in all cases, cell viability was .96%. Occasionally,
multiple cells migrated in the same region of the gel or
as a cluster using pathways made by previously migrated
tumor cells. In some cases, cells would stop for short
periods in the gel, resulting in inhomogeneities in
fluorescence intensity. Nonetheless, cell migration
through the gel was characterized by linear pathways
rich in proteolysis.
Cell–cell cooperation may participate in the invasive
program of tumor cells under certain conditions (25–
27). Specifically, uPAR-positive tumor or stromal cells
may participate in the invasiveness of uPAR-negative
tumor cells. We therefore used our in vitro 3-dimen-
sional invasion imaging method with a heterogeneous
cell population. We tested the hypothesis that uPAR-
expressing cells affect the invasive behavior of uPAR-
negative cells. To perform this experiment, we used the
T-47D cell line, which is less invasive than the HT1080
cell line, and a derivative of the T-47D cell line, T-47D
A2–1, which has been transfected with a uPAR-contain-
ing vector. The T-47D A2–1 transfectant expresses
uPAR and demonstrates greatly enhanced proteolytic
activity in comparison to the parental T-47D line (see
below). The use of the T-47D and T-47D A2–1 cell lines
avoids the introduction of other potentially confound-
ing variables with cells from different sources. The
T-47D cells were labeled with the fluorescent probe DiI,
as described in Materials and Methods. A single cell
suspension of 2 3 104 T-47D A2–1 cells and 2 3 104
DiI-labeled T-47D cells was prepared. These cells were
suspended in 50 ml of HBSS containing 6% gelatin and
layered atop a gel matrix containing DQ™ collagen.
After 30 min at 37°C, samples were placed on a 37°C
microscope stage. Forty to 50 image planes were col-
lected for the DiI probe (T-47D localization, red) and
another precisely matched image stack was collected at
a separate wavelength for DQ™ collagen (proteolytic
action, blue). DQ™ collagen fluorescence emission is
restricted to the location of, or trail of, T-47D A2–1
cells. Although sensitive imaging techniques have re-
vealed some pericellular proteolytic activity near T-47D
cells, the intensity of this fluorescence is too low to be
detected in these experiments. Figure 6 shows repre-
sentative examples of mixed tumor cell invasion exper-
iments. Figure 6A shows an example of a T-47D cell
following a path produced by the T-47D A2–1 cell. The
DiI emission profile in this figure is significantly larger
than the size of a cell. Since these cells are migrating
and time is required to capture an image and move the
stage to the next plane, some blurring of the images is
expected. Figure 6B shows results similar to those of
Fig. 6A except that the T-47D cell is migrating at an
Figure 4. A gallery of representative 3-dimensional images
showing HT1080 transmigration of these matrices. Images
represent the fluorescence intensities of matrices detected by
fluorescence of proteolytic action using DQ™ collagen (a) or
Bodipy-BSA (b). Scale bars 5 20 mm.
Figure 5. Effect of protease inhibitors on
migration across the nylon mesh-supported
gel matrices. The number of cells reaching
the bottom surface of the matrix after a 4 h
incubation at 37°C was divided by the number
of cells added to the top layer to determine
the fraction of cells that migrated across the
matrix. Experiments were performed in the
presence (open bars) and absence (striped
bars) of inhibitors. Although PAI-1 was found
to substantially inhibit cell appearance at the
bottom surface (a), 1, 10-phenanthroline
was found to have no effect (b).
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angle toward the pathway created by the T-47D A2–1
cell. In other examples (Fig. 6C), the pathways followed
by T-47D cells were not colinear with T-47D A2–1 cells.
Quantitative analyses of cell migration are shown in Fig.
7. This figure shows the migration ratio of T-47D and
T-47D A2–1 cells in the presence and absence of the
other cell type. As expected, migration of the uPAR-
expressing T-47D 2A-1 cell line was substantially greater
than the wild-type uPAR-negative T-47D cells when
examined separately. However, when the mixed cell
experiment was performed, the migration of the T-47D
2A-1 cells was not affected whereas the migration of the
DiI-labeled T-47D cells became indistinguishable from
their uPAR-expressing counterparts. One potential
mechanism contributing to this is matrix disruption
provided by the uPAR-positive cells (Fig. 6A).
DISCUSSION
The primary cause of death from cancer is cell invasion
of neighboring tissues and formation of distant metas-
tases. Pericellular proteolysis is a key step required for
the invasion of tumor cells. Pericellular proteolytic
activity is required for disruption of basement mem-
branes and interstitial tissues and the penetration of
cell layers. Two families of enzymes thought to partici-
pate in the pericellular proteolysis associated with the
invasive program of tumor cells are plasminogen acti-
vators and matrix metalloproteinases (2–9, 19). How-
ever, the relative importance of these two types of
enzymatic activities apparently varies among tumor cell
types (2–9, 19). The present study focused on pericel-
lular proteolysis-dependent events occurring during
tumor cell invasion of a model matrix.
The present study is of considerable interest from
both technological and physiological viewpoints. Using
an open mesh nylon grid for support, multiple gel
layers were deposited on the mesh. By adding a small
amount of gel to the mesh at a time, multiple layers
could be built up into a thicker matrix-like assembling
plywood. The open mesh also affords the ability to use
both transmitted light and epifluorescence microscopy
to image events in a sample. This is a substantial
Figure 6. 3-Dimensional image reconstruction of tumor cell
migration through model matrices containing DQ™ colla-
gen. Experiments were performed using T-47D cells that do
not express uPAR and T-47D A2–1 cells that express uPAR.
Equivalent numbers of cells were mixed and added to the top
of supported gel matrices. T-47D cells were labeled with DiI to
reveal their location in the gel (red in micrographs). The
locations proteolytic activity are shown in blue. Collagen
disruption likely mediated by uPAR-mediated enhancement
of uPA activity and uPA-mediated activation of MMPs (17)
and plasmin activation (24). A) A T-47D cell is following a
T-47D A2–1 cell across the matrix. B) A T-47D cell migrates at
an angle to intersect the pathway formed by a T-47D A2–1
cell. C) Two T-47D cells that are crossing the matrix without
directly after the T-47D A2–1 cell. (Quantitative data are
shown in Fig. 7.) Scale bars 5 20 mm.
Figure 7. Quantitative analysis of the effect of uPAR-positive
T-47D A2–1 cells on the invasive ability of uPAR-negative
T-47D cells. Experiments were performed as described in Fig.
6 and the text. The number of cells reaching the bottom
surface of the matrix after a 4 h incubation at 37°C was
divided by the number of cells added to the top layer to
determine the fraction of cells that migrated across the
matrix. The ability of T-47D cells to traverse the matrix was
measured in the absence (open bars) and presence (striped
bars) of T-47D A2–1 cells (a). The ability of T-47D cells to
cross the matrix was enhanced by the presence uPAR-express-
ing T-47D A2–1 cells. However, T-47D cells had no influence
on the ability of T-47D A2–1 cells to migrate across the gel (b).
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advantage over invasion assays that rely on cell migra-
tion through artificial pores. Another advantage of
these nylon mesh-supported matrices is that most of the
surface area is available for transmigration to the
bottom of the matrix. In contrast, only a small fraction
of a filter’s surface area is available in the form of pores
to permit migration to the bottom of the matrix. In
many experiments using the filter assay, cells must
‘squeeze’ through the pores in the plastic filters, an
action that has no clear counterpart in cell physiology.
It is not clear whether the pore assays are measuring the
kinetics of transmigration or the kinetics of finding an
available pore. Moreover, these gel matrices can also be
tailored to address specific experimental hypotheses. In
this study, for example, we included substrates (Bodipy-
BSA and DQ™ collagen) within the matrix that be-
come fluorescent upon proteolytic cleavage, thus re-
vealing the location of functioning enzymes. When
these assays were conducted for extended periods of
time, the pathways followed by cells during this model
transmigration process could be imaged. Our approach
is particularly valuable in studying transmigration since
bright-field microscopy is unrevealing under these cir-
cumstances because the refractive index of cells
matches that of the extracellular matrix. Thus, we have
developed the technology suitable for addressing sev-
eral critical issues surrounding the invasive ability of
cancer cells.
Proteolysis of the extracellular matrix is believed to
be necessary for the invasive and migratory capacity of
cells. The proteinases thought to be largely responsible
for the degradation of the extracellular matrix are the
matrix metalloproteinases and plasminogen activators
(2–9, 19). The detection of these activities in situ relies
on the generation of fluorescent peptides after protein
cleavage. To confirm the relevance of the Bodipy-BSA
and DQ™ collagen probes, we tested their ability to
disrupt matrices in the presence of the inhibitors PAI-1
and 1, 10-phenanthroline. PAI-1 and 1, 10-phenanthro-
line substantially inhibited the release of fluorescent
peptides from Bodipy-BSA and DQ™ collagen, respec-
tively. Thus, these probes are appropriate for the
detection of these enzymatic activities. The present
study demonstrates proteolysis and collagen disruption
during cell migration across these model matrices.
Although much work has suggested a role of collagen
disruption in cell migration through complex matrices,
our work provides direct evidence for the cell-mediated
disruption of collagen during tumor cell invasion.
Several previous studies have traced the pathways of
leukocyte movement in 3-dimensional gels (28, 29).
These studies are very time consuming because they
necessarily followed just one cell over a long period of
time. By detecting the enzymatic activities associated
with transmigration, we were able to image the migra-
tory pathways of many cells. By collecting image stacks
from different focal planes in a gel, we can collect data
from multiple cells from a single experiment.
We also confirmed the relevance of particular en-
zyme activities imaged in the present study with in vitro
migration in these model matrices. PAI-1 and 1, 10-
phenanthroline were incorporated into the matrices at
high concentrations before their solidification. PAI-1,
but not 1, 10-phenanthroline, was found to substan-
tially inhibit the ability of tumor cells to cross the
matrix. This is consistent with earlier studies indicating
that urokinase-type plasminogen activator plays an im-
portant role in tumor cell invasiveness (e.g., ref 30).
Since there is some variability in the relative impor-
tance of urokinase and matrix metalloproteinases
among different types of cancer cells (2–9, 19), this
result should not be interpreted to mean that metallo-
proteinases are unimportant to tumor cell invasion in
general.
Previous studies have shown that uPAR-positive cells
express an invasive phenotype (e.g., refs 8–11, 30).
uPAR-negative cells can also be invasive. One mecha-
nism that may account for the invasiveness of uPAR-
negative cells is cross-talk among uPAR-positive and
uPAR-negative cell types. For example, uPAR-negative
tumor cells may collaborate with uPAR-positive stromal
cells during invasion (e.g., ref 25). Having developed
the technology to observe proteolytic trails in matrices,
we examined the ability of uPAR-positive cells to facil-
itate the invasive behavior of uPAR-negative cells. To
perform this test, we used uPAR-negative T-47D cells
and T-47D transfectants expressing uPAR. We found
that the presence of uPAR-positive cells enhanced the
ability of uPAR-negative cells to migrate across the
matrix. The microscopy studies of Fig. 6 suggest that
the ability of uPAR-negative cells to follow uPAR-posi-
tive cells across a matrix can partially account for this.
Thus, matrix disruption by uPAR-positive cells could
facilitate a ‘follow the leader’ type mechanism during
matrix invasion by uPAR-negative cells.
The 3-dimensional model of cell transmigration and
extracellular proteolysis described above should be
generally applicable in studies of invasion and transmi-
gration. For example, the extracellular matrix compo-
nents could be tailored to reflect specific microenviron-
ments. Other cell types could be added to the matrix
itself during formation and to the top or bottom of the
nylon mesh-supported matrix after formation. More-
over, it should be possible to monitor several biochem-
ical reactions in addition to the proteolytic reactions
noted above. For example, it is known that tumor cells
can produce superoxide anions (31). Such oxidants
could be detected in this tissue-like environment as
well. Thus, we expect that this approach will become a
valuable tool in cancer biology.
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